These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12684113)

  • 1. Anodic voltammetric assay of lansoprazole and omeprazole on a carbon paste electrode.
    Radi A
    J Pharm Biomed Anal; 2003 Apr; 31(5):1007-12. PubMed ID: 12684113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrochemical studies and differential pulse polarographic analysis of lansoprazole in pharmaceuticals.
    Yardimci C; Ozaltin N
    Analyst; 2001 Mar; 126(3):361-6. PubMed ID: 11284340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of pantoprazole by adsorptive stripping voltammetry at carbon paste electrode.
    Radi A
    Farmaco; 2003 Jul; 58(7):535-9. PubMed ID: 12818693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voltammetric behaviour of rabeprazole at a glassy carbon electrode and its determination in tablet dosage form.
    Radi A; Abd El-Ghany N; Wahdan T
    Farmaco; 2004 Jul; 59(7):515-8. PubMed ID: 15231426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of lansoprazole in pharmaceutical capsules by flow injection analysis using UV-detection.
    Yeniceli D; Dogrukol-Ak D; Tuncel M
    J Pharm Biomed Anal; 2004 Sep; 36(1):145-8. PubMed ID: 15351058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alternating current polarographic behavior and determination of lansoprazole and omeprazole in dosage forms and biological fluids.
    El-Enany N; Belal F; Rizk M
    J Biochem Biophys Methods; 2008 Apr; 70(6):889-96. PubMed ID: 18395265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of Lansoprazole in pharmaceutical dosage forms by two different spectroscopic methods.
    Ozaltín N
    J Pharm Biomed Anal; 1999 Jul; 20(3):599-606. PubMed ID: 10701978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemometric determination of rabeprazole sodium in presence of its acid induced degradation products using spectrophotometry, polarography and anodic voltammetry at a glassy carbon electrode.
    Moneeb MS
    Pak J Pharm Sci; 2008 Jul; 21(3):214-24. PubMed ID: 18614415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An electrochemical sensor based on an Eriochrome Black T polymer and deep eutectic solvent for the simultaneous determination of omeprazole and lansoprazole.
    Mostafiz B; Fotouhi L; Dorraji PS
    Anal Methods; 2020 Aug; 12(32):4072-4079. PubMed ID: 32760946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole.
    Sharma VK
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S18-21. PubMed ID: 10597120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products.
    El-Sherif ZA; Mohamed AO; El-Bardicy MG; El-Tarras MF
    Chem Pharm Bull (Tokyo); 2006 Jun; 54(6):814-8. PubMed ID: 16755049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of suspension formulations of lansoprazole and omeprazole stored in amber-colored plastic oral syringes.
    DiGiacinto JL; Olsen KM; Bergman KL; Hoie EB
    Ann Pharmacother; 2000 May; 34(5):600-5. PubMed ID: 10852086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential pulse polarographic investigation of lansoprazole and rabeprazole using dropping mercury electrode.
    Gärtner P; Zschimmer K; Knoth H
    Pharmazie; 2009 Jun; 64(6):371-5. PubMed ID: 19618672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrochemical study of the antineoplastic agent etoposide at carbon paste electrode and its determination in spiked human serum by differential pulse voltammetry.
    Radi AE; Abd-Elghany N; Wahdan T
    Chem Pharm Bull (Tokyo); 2007 Sep; 55(9):1379-82. PubMed ID: 17827766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations.
    Wahbi AA; Abdel-Razak O; Gazy AA; Mahgoub H; Moneeb MS
    J Pharm Biomed Anal; 2002 Nov; 30(4):1133-42. PubMed ID: 12408904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preformulation investigation of the novel proton pump inhibitor lansoprazole.
    Kristl A; Vrecer F
    Drug Dev Ind Pharm; 2000 Jul; 26(7):781-3. PubMed ID: 10872099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole.
    Andersson T; Holmberg J; Röhss K; Walan A
    Br J Clin Pharmacol; 1998 Apr; 45(4):369-75. PubMed ID: 9578184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of proton pump inhibitors on thyroid hormone metabolism in rats: a comparison of UDP-glucuronyltransferase induction.
    Masubuchi N; Hakusui H; Okazaki O
    Biochem Pharmacol; 1997 Dec; 54(11):1225-31. PubMed ID: 9416973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
    Li XQ; Andersson TB; Ahlström M; Weidolf L
    Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.